IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.33% | -0.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.33% | -0.38% | |||
| Cost of Revenue | 2.51% | 1.73% | |||
| Gross Profit | -3.69% | -1.64% | |||
| SG&A Expenses | 0.60% | 2.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.08% | 1.90% | |||
| Operating Income | -8.52% | -4.88% | |||
| Income Before Tax | -10.96% | -4.85% | |||
| Income Tax Expenses | -16.20% | 2.63% | |||
| Earnings from Continuing Operations | -9.62% | -6.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.62% | -6.59% | |||
| EBIT | -8.52% | -4.88% | |||
| EBITDA | -7.19% | -4.24% | |||
| EPS Basic | -9.40% | -6.22% | |||
| Normalized Basic EPS | -8.12% | -4.47% | |||
| EPS Diluted | -9.17% | -6.34% | |||
| Normalized Diluted EPS | -8.13% | -4.47% | |||
| Average Basic Shares Outstanding | -0.25% | -0.39% | |||
| Average Diluted Shares Outstanding | -0.24% | -0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||